Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.

Oran, B

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. [electronic resource] - Leukemia Dec 2007 - 2540-4 p. digital

Publication Type: Comparative Study; Letter

1476-5551

10.1038/sj.leu.2404828 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation--statistics & numerical data
Humans
Immunosuppressive Agents--administration & dosage
Leukemia, Myeloid, Acute--drug therapy
Lymphocyte Transfusion--statistics & numerical data
Male
Middle Aged
Myeloablative Agonists--administration & dosage
Myelodysplastic Syndromes--drug therapy
Palliative Care
Recurrence
Remission Induction
Salvage Therapy
Transplantation Conditioning--methods
Transplantation, Homologous